We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
High levels of uric acid in systemic lupus erythematosus is associated with pulmonary hypertension.
- Authors
Kim, Ki‐Jo; Baek, In‐Woon; Park, Yune‐Jung; Yoon, Chong‐Hyeon; Kim, Wan‐Uk; Cho, Chul‐Soo
- Abstract
Aim To estimate the point prevalence of pulmonary hypertension ( PH) and determine the associated factors for PH in patients with systemic lupus erythematosus ( SLE). Methods A prospective cross-sectional study of 114 patients with SLE was conducted in a single tertiary center. Transthoracic echocardiography was performed to estimate the pulmonary arterial pressures. PH was defined as resting systolic pulmonary artery pressure ( sPAP) ≥ 40 mmHg, in the absence of left heart disease. Results PH was identified in nine patients (7.9%) who had few cardiopulmonary symptoms. SLE patients with PH had higher SLE disease activity index score. In particular, serum uric acid (UA) was significantly higher in patients with PH than in those without PH. In multivariate analysis, UA remained significant for the presence of PH. Moreover, serum UA level correlated significantly with plasma NT-pro-B-type natriuretic peptide level as well as sPAP. At the cutoff level of 6.5 mg/dL, serum UA had reasonable accuracy for predicting the presence of PH in SLE patients (sensitivity 66.7% and specificity 96.2%). Conclusion A significant number of SLE patients in rheumatology practice have undiagnosed PH with few discernible symptoms. Serum UA level may be useful as a surrogate marker for screening of PH in patients with SLE.
- Subjects
PULMONARY hypertension; SYSTEMIC lupus erythematosus; URIC acid; CARDIOVASCULAR diseases; HYPERTENSION
- Publication
International Journal of Rheumatic Diseases, 2015, Vol 18, Issue 5, p524
- ISSN
1756-1841
- Publication type
Article
- DOI
10.1111/1756-185X.12262